Endo’s Opana IR Should Not Add Pediatric Data To Labeling, US FDA Panel Says

 
• By Sue Sutter
  
FDA Advisory Committee Feature image
An AdComm voted against approval of pediatric labeling for Opana IR.

More from US FDA Performance Tracker

More from Regulatory Trackers